Back to search

Article

Cross-Platform Validation of Neurotransmitter Release Impairments in Schizophrenia Patient-Derived <i>NRXN1</i> -Mutant Neurons

2020-11-03

Abstract excerpt

<h4>ABSTRACT</h4> Heterozygous NRXN1 deletions constitute the most prevalent currently known single-gene mutation predisposing to schizophrenia. Previous studies showed that engineered heterozygous NRXN1 deletions impaired neurotransmitter release in human neurons, suggesting a synaptic pathophysiological mechanism. Utilizing this observation for drug discovery, however, requires confidence in its robustness an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5f80f45b-95d0-5cfe-bbae-9d858d659306
DOI
10.1101/2020.11.03.366617
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cross-Platform Validation of Neurotransmitter Release Impairments in Schizophrenia Patient-Derived <i>NRXN1</i> -Mutant NeuronsDOI 10.1101/2020.11.03.366617
Select a neighboring publication to make it the new centre.